Walgreens to Close 60 VillageMD Locations

By Robert Michel | From the Volume XXXI, No. 5 – April 8, 2024 Issue

CEO SUMMARY: Following substantial losses in fiscal 2023, Walgreens is working to cut costs and reduce overhead. One casualty in this effort will be the closure of 60 of the 360 primary care clinics in retail pharmacy stores built by Walgreens in recent years. These actions demonstrate th…

Read More

---

Published Data Show Claim Denials on the Rise, But Why?

By Virchow | From the Volume XXXI, No. 2 – February 5, 2024 Issue

…

Read More

---

Year’s Top 10 Lab Stories Contain Surprises & Twists

By Robert Michel | From the Volume XXX, Number 18 – December 26, 2023 Issue

CEO SUMMARY: With the SARS-CoV-2 pandemic now in the rearview mirror of the nation’s clinical labs and pathology groups, the important news stories of 2023 were mostly about developments where the consequences will influence laboratory operations in coming years. Artificial intelligence…

Read More

---

December 4, 2023, Intelligence: Late-Breaking Lab News

By Robert Michel

You may have thought that the long-running saga of the now-defunct Theranos had ended. But no, there is continuing litigation in the Grand Canyon State. A class action suit—In re Arizona Theranos, Inc., Litigation, Case No. 2:16-cv-2138—continues to move forward in …

Read More

---

Hospitals, Pharmacies Struggle to Be Profitable

By Robert Michel | From the Volume XXX, Number 15 – October 23, 2023 Issue

CEO SUMMARY: Pharmaceutical companies may be posting strong growth in revenue and profits. But that’s not true for the nation’s largest retail pharmacy chains. Rite Aid’s Chapter 11 bankruptcy filing earlier this month put a spotlight on financial stress at all the retail pharmacy c…

Read More

---

May 16, 2022 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXIX, No. 7 – May 16, 2022 Issue

Chalk up another lab outreach deal for Labcorp. The Burlington, N.C.-based company has agreed to acquire certain assets of AtlantiCare’s clinical laboratory outreach business. The deal was announced on May 9, with no financial terms disclosed. The outreach business of AtlantiCare, bas…

Read More

---

XIFIN’s Acquisition of OmniSYS Will Unite Lab with Pharmacy

By Robert Michel

This is an excerpt of a 1,829-word article in the January 10, 2022 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: XIFIN’s acquisition of OmniSys, a pharmacy technology company, is the latest evidence that …

Read More

---

XIFIN Buys OmniSYS, Bridges Lab to Pharmacy

By Robert Michel | From the Volume XXIX, No. 1 – January 10, 2022 Issue

CEO SUMMARY: XIFIN’s acquisition of pharmacy technology company OmniSYS is the latest evidence that retail pharmacies are preparing to become a new front door to healthcare for consumers. The deal allows XIFIN to bring clinical lab information about patients directly to pharmacist…

Read More

---

Theranos Lost $585 Mil. in 2015, Had Revenue of Just $500,000

By Robert Michel | From the Volume XXVIII, No. 17 – December 20, 2021 Issue

AMONG THE BEST-KEPT SECRETS at Theranos during its glory days of 2013, 2014, and 2015—when the news media hailed now-disgraced founder and ex-CEO Elizabeth Holmes as a business genius to match Apple founder Steve Jobs—was the actual revenue the company was generating from its clinic…

Read More

---

Former Theranos Lab Director Makes News at Elizabeth Holmes Trial

By Robert Michel | From the Volume XXVIII, No. 14 – October 18, 2021 Issue

This is an excerpt of a 1,867-word article in the October 18, 2021 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: During the trial, a pathologist who was a former Theranos lab director testified about the little…

Read More

---